ornithine has been researched along with arginyl-glycyl-aspartic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouziotis, P; Fragogeorgi, E; Kagadis, GC; Loudos, G; Mihailidis, D; Nikiforidis, GC; Psimadas, D; Tsiapa, I; Tsotakos, T; Varvarigou, A; Xanthopoulos, S | 1 |
| Bouziotis, P; Fragogeorgi, EA; Kagadis, GC; Karnabatidis, D; Loudos, G; Palamaris, L; Paravatou-Petsotas, M; Psimadas, D; Tsiapa, I; Varvarigou, AD; Xanthopoulos, S | 1 |
2 other study(ies) available for ornithine and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
Biological evaluation of an ornithine-modified (99m)Tc-labeled RGD peptide as an angiogenesis imaging agent.
Topics: Animals; Cell Line, Tumor; Drug Stability; Female; Humans; Isotope Labeling; Magnetic Resonance Imaging; Mice; Neovascularization, Pathologic; Oligopeptides; Ornithine; Quality Control; Rhenium; Technetium; Tomography, Emission-Computed, Single-Photon | 2013 |
Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.
Topics: Animals; Cell Line, Tumor; Glioblastoma; Humans; Integrin alphaVbeta3; Isotope Labeling; Mice; Mice, SCID; Neovascularization, Pathologic; Oligopeptides; Ornithine; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Tissue Distribution | 2014 |